IRIS
GITTO, Rosaria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.627
EU - Europa 9.160
AS - Asia 5.475
SA - Sud America 2.052
AF - Africa 163
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 8
Totale 35.495
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.429
RU - Federazione Russa 3.248
SG - Singapore 2.320
BR - Brasile 1.821
IE - Irlanda 1.567
SE - Svezia 1.335
CN - Cina 1.306
IT - Italia 619
UA - Ucraina 605
VN - Vietnam 592
HK - Hong Kong 581
DE - Germania 545
GB - Regno Unito 354
FI - Finlandia 313
IN - India 250
FR - Francia 140
CA - Canada 96
AR - Argentina 90
PL - Polonia 70
CZ - Repubblica Ceca 61
MX - Messico 61
BE - Belgio 57
JP - Giappone 54
AT - Austria 52
BD - Bangladesh 52
NL - Olanda 49
IQ - Iraq 47
ZA - Sudafrica 46
TR - Turchia 41
MA - Marocco 39
EC - Ecuador 37
UZ - Uzbekistan 33
CI - Costa d'Avorio 32
ES - Italia 28
ID - Indonesia 20
CO - Colombia 19
CL - Cile 17
PK - Pakistan 16
PY - Paraguay 16
UY - Uruguay 16
VE - Venezuela 16
IR - Iran 15
GR - Grecia 14
JO - Giordania 14
EG - Egitto 13
AZ - Azerbaigian 12
LT - Lituania 12
LV - Lettonia 12
PE - Perù 12
AE - Emirati Arabi Uniti 11
NO - Norvegia 10
OM - Oman 10
DO - Repubblica Dominicana 9
KE - Kenya 9
KZ - Kazakistan 9
NP - Nepal 9
AL - Albania 8
IL - Israele 8
RO - Romania 8
BO - Bolivia 7
KG - Kirghizistan 7
MY - Malesia 7
NZ - Nuova Zelanda 7
SK - Slovacchia (Repubblica Slovacca) 7
AM - Armenia 6
HN - Honduras 6
PA - Panama 6
PT - Portogallo 6
SA - Arabia Saudita 6
CH - Svizzera 5
CR - Costa Rica 5
DZ - Algeria 5
JM - Giamaica 5
KR - Corea 5
LB - Libano 5
LK - Sri Lanka 5
MD - Moldavia 5
PS - Palestinian Territory 5
TN - Tunisia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BG - Bulgaria 4
IS - Islanda 4
LU - Lussemburgo 4
NI - Nicaragua 4
PH - Filippine 4
RS - Serbia 4
SN - Senegal 4
AU - Australia 3
CY - Cipro 3
DK - Danimarca 3
EE - Estonia 3
GE - Georgia 3
GT - Guatemala 3
HU - Ungheria 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
MK - Macedonia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
BH - Bahrain 2
Totale 35.469
Salva come PNG Salva come JPEG
Città #
Dallas 10.061
Moscow 1.596
Dublin 1.565
Chandler 1.189
Singapore 1.139
Jacksonville 1.137
Ashburn 1.133
Nyköping 862
Beijing 599
Hong Kong 577
Dong Ket 358
Los Angeles 298
Princeton 254
Dearborn 244
Cambridge 215
Medford 210
Des Moines 187
Messina 177
The Dalles 165
Ann Arbor 158
Boardman 150
Hyderabad 125
Buffalo 116
São Paulo 115
Munich 109
New York 108
Ho Chi Minh City 93
Woodbridge 89
Lancaster 86
Wilmington 69
Pune 63
Redondo Beach 55
Brussels 53
San Mateo 53
Tianjin 53
Warsaw 53
Hanoi 52
Turku 52
Belo Horizonte 50
Jinan 50
Seattle 49
Brooklyn 48
Rio de Janeiro 46
Brno 43
Shenyang 41
Tokyo 41
Vienna 41
Denver 36
London 36
Milan 36
Catania 35
Brasília 34
Houston 33
Johannesburg 33
Santa Clara 33
Tashkent 33
Abidjan 32
Chicago 31
Nanjing 31
Atlanta 30
Council Bluffs 30
Frankfurt am Main 30
Montreal 30
Orem 30
Phoenix 30
Rome 30
Stockholm 29
Haikou 28
Helsinki 28
Amsterdam 26
Curitiba 26
Washington 25
Nuremberg 23
Porto Alegre 23
Baghdad 22
Chennai 21
Poplar 21
Taizhou 21
Hangzhou 20
Manchester 20
Toronto 20
Düsseldorf 19
Fuzhou 19
Lappeenranta 19
Ningbo 19
Boston 18
Ottawa 18
Zhengzhou 18
Francofonte 17
Goiânia 17
Guangzhou 17
Nanchang 17
Ribeirão Preto 17
Augusta 16
Fortaleza 16
Guayaquil 16
Hebei 16
Turin 16
Betim 15
Campinas 15
Totale 25.318
Salva come PNG Salva come JPEG
Nome #
[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines: synthesis and stereochemistry 4.692
[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines: stereochemistry and anticonvulsant activity 4.664
1-aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: Novel AMPA receptor antagonists 251
1-Aryl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide derivatives: synthesis and biological evaluation 232
1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: non-competitive AMPA receptors antagonists 230
1,4-benzodiazepine derivatives as anticonvulsant agents in DBA/2 mice 227
Chemical exploration of 4-(4-fluorobenzyl)piperidine fragment for the development of new tyrosinase inhibitors 203
1-Benzylpiperidine derivatives: design and synthesis of new compounds as tyrosinase inhibitors from Agaricus bisporus 177
4,5-Dihydro-7,8-dimethoxy-1-phenyl-3H-2,3-benzodiazepin-4-one 173
4-Fluorobenzylpiperazine-Containing Derivatives as Efficient Inhibitors of Mushroom Tyrosinase 173
AMPA receptor antagonists: Synthesis and pharmacological evaluation 170
3,5-dihydro-4H-2,3-benzodiazepine-4-thiones: A new class of AMPA receptor antagonists 168
Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases 167
7,8-methylenedioxy-4H-2,3-benzodiazepin-4-ones as novel AMPA receptor antagonists 161
Anticonvulsant agent: enhancement of physicochemical properties 159
5H-[1,2,4]OXADIAZOLO[5,4-D][1,5]BENZOTHIAZEPINES - SYNTHESIS AND STEREOCHEMISTRY 156
4-[1-(4-Fluorobenzyl)-4-hydroxy-1H-indol-3-yl]-2-hydroxy-4-oxobut-2-enoic acid as a prototype to develop dual inhibitors of HIV-1 integration process. 153
Targeting Tyrosinase: Development and Structural Insights of Novel Inhibitors Bearing Arylpiperidine and Arylpiperazine Fragments 152
5H-[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines as anticonvulsant agents in DBA/2 mice. 151
Design and optimization of isoquinoline-sulfonamides as potent and selective inhibitors of human carbonic anhydrase VII 150
Exploiting the 1-(4-fluorobenzyl)piperazine fragment for the development of novel tyrosinase inhibitors as anti-melanogenic agents: Design, synthesis, structural insights and biological profile 149
Seeking new approach for therapeutic treatment of cholera disease via inhibition of bacterial carbonic anhydrases: experimental and theoretical studies for sixteen benzenesulfonamide derivatives 148
5-Phenyl-9H-1,3-dioxolo[4,5-h][2,3]-benzodiazepin-8(7H)-one 146
3D Pharmacophore model and synthesys of NMDA receptor subunit NR2B antagonists 145
A new potential approach to block HIV-1 replication via protein–protein interaction and strand-transfer inhibition 144
Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl)benzenesulfonamide moiety 143
Carbonic anhydrase inhibitors: Design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms 142
Design and synthesis of acetylcholinesterase inhibitors 141
Identification of Potent and Selective Human Carbonic Anhydrase VII (hCA VII) Inhibitors 141
A Combination of Pharmacophore and Docking-based Virtual Screening to Discover new Tyrosinase Inhibitors 141
Looking toward the Rim of the Active Site Cavity of Druggable Human Carbonic Anhydrase Isoforms 140
2,3-Benzodiazepines as potential AMPA receptors antagonists 139
A structure-based approach to ligand discovery for inhibition of HIV-1 IN-LEDGF/p75 interaction: a new target for anti-AIDS therapy 137
InVivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant Agents 136
Discovery of benzimidazole-based Leishmania mexicana cysteine protease CPB2.8ΔCTE inhibitors as potential therapeutics for leishmaniasis 134
Synthesis and biochemical evaluation of 5-(pyridin-4-yl)-4H-1,2,4-triazol-4-amine-based inhibitors of tyrosinase from Agaricus bisporus 133
Synthesis, resolution, stereochemistry, and molecular modeling of (R)- and (S)-2-acetyl-1-(4 '-chlorophenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline AMPAR antagonists 133
DISCOVERY OF NEW INDOLE DERIVATES AS NEUROPROTECTIVE AGENTS 132
Discovery of a new potent inhibitor of mushroom tyrosinase (Agaricus bisporus) containing 4-(4-hydroxyphenyl)piperazin-1-yl moiety 132
4-Sulfamoylphenylalkylamides as Inhibitors of Carbonic Anhydrases Expressed in Vibrio cholerae 132
7,9-Dihydro-1,3-dioxolo[4,5-h][2,3]benzodiazepin-8(7H)-ones as anticonvulsant agents 130
Antiretroviral strategy using multi-target agents 130
Rational design of small molecules able to inhibit α-synuclein amyloid aggregation for the treatment of Parkinson’s disease 130
Computational methods to analyze and predict the binding mode of inhibitors targeting both human and mushroom tyrosinase 129
7,11b-dihydro-9,10-dimethoxy-3,11b- diphenyl[1,2,4]oxadiazolo[5,4-a]-[2,3]benzodiazepin-6(5H)-one 128
Identification of isoquinoline-sulfonamides as potent and selective carbonic anhydrase inhibitors 128
In Silico-Guided Identification of New Potent Inhibitors of Carbonic Anhydrases Expressed in Vibrio cholerae 128
ENANTIOSEPARATION AND COMPLEXATION STUDIES ON 2,3-BENZODIAZEPINES 127
3D Pharmacophore Models for 1,2,3,4-Tetrahydroisoquinoline Derivatives Acting as Anticonvulsant Agents 127
3D pharmacophore model and the synthesis of NMDA receptor subunit NR2B antagonists 127
Anticonvulsant activity and plasma level of 2,3-benzodiazepin- 4-ones (CFMs) in genetically epilepsy-prone rats 126
Combined strategies for the discovery of ionotropic glutamate receptor antagonists 126
Binding mode investigation and SAR studies of HIV-1 integrase inhibitors 125
Discovery of potent and selective inhibitors of druggable carbonic anhydrase isoforms 124
Searching for indole derivatives as potential mushroom tyrosinase inhibitors 124
In Silico Strategy for Targeting the mTOR Kinase at Rapamycin Binding Site by Small Molecules 124
Nuovi Antagonisti Noncompetitivi del Recettore AMPA a struttura tetraidroisochinolinica, 123
Annelated 1,5-benzothiazepines 123
Evaluation of 4-(4-Fluorobenzyl)piperazin-1-yl]-Based Compounds as Competitive Tyrosinase Inhibitors Endowed with Antimelanogenic Effects 123
Small molecules targeting the interaction between HIV-1 integrase and LEDGF/p75 cofactor. 122
P158-DEVELOPMENT OF FLEXIBLE ARYLSULFONAMIDES AS POTENTIAL MULTITARGET ANTICANCER AGENTS 122
Novel Potent Anticonvulsant Agent Containing a Tetrahydroisoquinoline Skeleton. 121
Nuovi ligandi del recettore NR2B/NMDA a struttura indolica 121
Synthesis and structure-active relationship of 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline anticonvulsants 121
HIV-1 integrase strand-transfer inhibitors: Design, synthesis and molecular modeling investigation 121
Design, synthesis and in vitro evaluation of 4-fluorobenzyl- and 4-hydroxyphenyl-based compounds targeting tyrosinases 121
PROGETTAZIONE E SINTESI DI NUOVI DKA ANALOGHI COME POTENZIALI INIBITORI DELL’INTEGRASI DELL’HIV-1 120
Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as Potent Carbonic Anhydrase Inhibitors: Synthesis, Biological Evaluation, and Enzyme−Ligand X-ray Studies 120
Small Molecules Targeting Protein–Protein Interactions: A Promising Anti-HIV Strategy 118
2-Acetil-1-(4'-clorofenil)-6,7-dimetossi-1,2,3,4-tetraidroisochinolina (Ps3Ac) Potente AMPA-antagonista: Definizione del Profilo Enantiofarmacobiologico 118
Exploring the MUC1/CIN85 interaction to investigate a small library of peptide inhibitors as potential anti-metastatic agents 118
Binding modes of noncompetitive AMPA antagonists: a computational approach 117
Nuovi Antagonisti Non-Competitivi Del Recettore NMDA/NR2b: Design e Sintesi” 117
From NMDA receptor antagonists to discovery of selective σ2 receptor ligands 116
ANNELATED 1,5-BENZODIAZEPINES .1. 3-MEMBERED, 4-MEMBERED, AND 5-MEMBERED RINGS. 115
Nuovi selettivi inibitori dell'anidrasi carbonica: sintesi, SAR e studi sull'interazione enzima/inibitore 115
The 1-(4-fluorobenzyl)piperazine fragment for the development of novel tyrosinase inhibitors 115
Analysis of structure-activity relationships in a series of 4-(1-piperazinyl)phenol-based derivatives as competitive inhibitors of Tyrosinase 115
ELECTRONIC-PROPERTIES OF THIENODIAZEPINE AND BENZODIAZEPINE DERIVATIVES 114
Synthesis of new pyridazine derivatives as potential anti-HIV-1 agents 114
Discovery and optimization of isoquinoline-derived inhibitors of human Carbonic Anhydrases (hCAs) 114
Probing the molecular interactions between the human Carbonic Anhydrases (hCAs) and a novel class of benzenesulfonamides 113
ANNELATED 1,5-BENZODIAZEPINES .2. 6 MEMBERED RINGS 112
INVESTIGATION ON PYRIDINYL-1,2,4-TRIAZOLE-BASED COMPOUNDS AS -SYN AGGREGATION INHIBITORS FOR TREATING PARKINSON’S DISEASE 112
Searching for alpha-syn inhibitors to fight Parkinson’s disease 112
Le acque potabili in provincia di Messina - approvvigionamento e distribuzione 111
Serendipitous discovery of indole derivatives as potent tyrosinase inhibitors 111
Computational and synthetic approaches for developing Lavendustin B derivatives as allosteric inhibitors of HIV-1 integrase 111
Structural optimization and in vitro evaluation of new 1-(4-fluorobenzyl)piperazine derivatives as inhibitors of Tyrosinase from Agaricus bisporus 111
Exploring the chemical space of 3-chloro-4-fluorophenyl-based compounds as tyrosinase inhibitors 110
Proprietà elettroniche di derivati tieno- e benzo-diazepinici 110
Anticonvulsant activity of tetrahydroisoquinoline derivatives as potential new AMPA receptor antagonists 109
Sintesi e SAR di nuovi inibitori dell'acetilcolinesterasi come potenziali agenti anti-Alzheimer 109
Computational Studies to Discover a New NR2B/NMDA Receptor Antagonist and Evaluation of Pharmacological Profile 109
PROGETTAZIONE E SINTESI DI NUOVI DERIVATI ISOCHINOLINICI COME AGENTI ANTICONVULSIVANTI MULTITARGET 108
PROGETTAZIONE E SINTESI DI NUOVI DKA ANALOGHI COME POTENZIALI INIBITORI DELL'INTEGRASI DELL'HIV-1 108
New indole derivatives as promising ligands for ifenprodil site of NR2B/NMDA receptors 108
Discovery of HIV-1 Integrase and cellular cofactor LEDGF/p75 interaction inhibitors 105
Antiretroviral strategy: design and synthesis of HIV-1 IN-LEDGF/p75 interaction inhibitors 105
Synthesis, biological evaluation and docking studies of NR2B/NMDA receptor antagonists 105
Totale 22.473
Salva come PNG Salva come JPEG
Categoria #
all - tutte 101.997
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.997
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.249 0 0 0 0 0 175 15 185 49 211 162 452
2021/20221.596 38 201 32 66 64 30 135 59 38 79 320 534
2022/20234.717 368 418 208 423 348 464 94 242 1.912 16 168 56
2023/20241.343 94 189 81 253 107 235 20 64 5 155 23 117
2024/20255.302 83 103 124 311 248 150 149 1.203 1.297 318 493 823
2025/202617.799 733 3.519 7.511 1.313 1.281 3.442 0 0 0 0 0 0
Totale 35.847